ImmunityBio, Inc. IBRX Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s common stock, shares, outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s common stock, shares, outstanding?
- ImmunityBio, Inc. (IBRX) reported common stock, shares, outstanding of $1.05B in Q1 2026.
- How has ImmunityBio, Inc.'s common stock, shares, outstanding changed year-over-year?
- ImmunityBio, Inc.'s common stock, shares, outstanding increased by 22.7% year-over-year, from $853.56M to $1.05B.
- What is the long-term trend for ImmunityBio, Inc.'s common stock, shares, outstanding?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s common stock, shares, outstanding has grown at a 21.5% compound annual growth rate (CAGR), from $382.24M to $1.01B.